Clinical Trial Update: Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis [Phase 2]

View source ↗

Summary

Phase II clinical study evaluating the combination of Adebrelimab and Apatinib in unresectable locally advanced non-small cell lung cancer, including patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Radiation Pneumonitis

Drugs mentioned

• Adebrelimab (adebrelimab)
• Apatinib (apatinib)

Snippet

Sponsor: Wei Zhou | Conditions: Unresectable Locally Advanced Non-small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING